Stable surface expression of a gene for Helicobacter pylori toxic porin protein with pBAD expression system

Zhixiang Peng1, Xi Wei, Zhengmei Lin

  • 1Department of Endodontics, Guanghua College of Stomatology, Sun Yat-Sen University, Guangzhou, 510055, China. pengzhixiang@gmail.com

Insights

Helicobacter pylori outer membrane protein HopE, a potential vaccine candidate, was successfully expressed on E. coli surfaces. The pBAD system demonstrated superior efficiency for HopE surface expression compared to the lac operon system.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Vaccinology

Background:

  • Helicobacter pylori (H. pylori) infection is a primary cause of peptic and duodenal diseases.
  • Outer membrane proteins (OMPs) of H. pylori are crucial for pathogenesis and potential vaccine targets.
  • HopE, a conserved porin-like outer membrane protein, shows promise as a vaccine candidate.

Purpose of the Study:

  • To achieve stable surface expression of the potentially host cell-toxic H. pylori outer membrane protein, HopE, in E. coli.
  • To compare the efficacy of the pBAD and lac operon expression systems for HopE surface display.

Main Methods:

  • The hopE gene was cloned into the pBAD and lac operon-regulated expression systems.
  • Escherichia coli (E. coli) LMG 194 strains were transformed with the constructed plasmids.
  • Protein expression was induced and confirmed using indirect immunofluorescence assays.

Main Results:

  • All tested E. coli colonies transformed with the pBAD expression system successfully expressed HopE protein on their surface after arabinose induction.
  • Only one out of five E. coli colonies transformed with the lac operon-regulated plasmid expressed HopE.
  • Indirect immunofluorescence confirmed the surface localization of HopE in E. coli.

Conclusions:

  • The pBAD expression system is highly efficient for achieving stable surface expression of H. pylori HopE in E. coli.
  • HopE can be successfully displayed on the E. coli surface, supporting its development as a potential vaccine candidate.